GetTopicDetailResponse(id=e891531944f, topicName=惰性非霍奇金淋巴瘤, introduction=惰性非霍奇金淋巴瘤, content=null, image=null, comments=1, allHits=1769, url=https://h5.medsci.cn/topic?id=53194, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88629, tagList=[TagDto(tagId=88629, tagName=惰性非霍奇金淋巴瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2245434, encodeId=e1122245434fa, content=<a href='/topic/show?id=e891531944f' target=_blank style='color:#2F92EE;'>#惰性非霍奇金淋巴瘤#</a> <a href='/topic/show?id=ff28116128bb' target=_blank style='color:#2F92EE;'>#侵襲性大B細胞淋巴瘤#</a>, objectTitle=【AJH】CAR-T治療轉(zhuǎn)化的惰性非霍奇金淋巴瘤和De Novo侵襲性LBCL的結局對比, objectType=article, longId=857246, objectId=5b1985e246b7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241228/1735387119903_8538692.jpg, objectUrl=/article/show_article.do?id=5b1985e246b7, replyNumber=0, likeNumber=44, createdTime=2024-12-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5b1985e246b7, moduleTitle=【AJH】CAR-T治療轉(zhuǎn)化的惰性非霍奇金淋巴瘤和De Novo侵襲性LBCL的結局對比, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5b1985e246b7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221197, encodeId=34a4222119e6a, content=<a href='/topic/show?id=7dc82898075' target=_blank style='color:#2F92EE;'>#免疫化療#</a> <a href='/topic/show?id=e891531944f' target=_blank style='color:#2F92EE;'>#惰性非霍奇金淋巴瘤#</a> <a href='/topic/show?id=7044118063c6' target=_blank style='color:#2F92EE;'>#Copanlisib#</a>, objectTitle=基于copanlisib和利妥昔單抗的免疫化療對復發(fā)惰性B細胞淋巴瘤的3期研究：CHRONOS-4研究, objectType=article, longId=838997, objectId=921f83899e47, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240703/1719981273634_5579292.jpg, objectUrl=/article/show_article.do?id=921f83899e47, replyNumber=0, likeNumber=226, createdTime=2024-08-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=921f83899e47, moduleTitle=基于copanlisib和利妥昔單抗的免疫化療對復發(fā)惰性B細胞淋巴瘤的3期研究：CHRONOS-4研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=921f83899e47)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1222740, encodeId=9ff61222e4070, content=<a href='/topic/show?id=518761566e4' target=_blank style='color:#2F92EE;'>#來那度胺#</a>治療<a href='/topic/show?id=e891531944f' target=_blank style='color:#2F92EE;'>#惰性非霍奇金淋巴瘤#</a>的長期預后, objectTitle=Clin Cancer Res：利妥昔單抗+來那度胺→來那度胺治療惰性非霍奇金淋巴瘤的長期預后, objectType=article, longId=216893, objectId=aac0216893ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202199/1631192803093_2110107.JPG, objectUrl=/article/show_article.do?id=aac0216893ff, replyNumber=0, likeNumber=141, createdTime=2022-05-27, rootId=0, userName=清風徐來2022, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aac0216893ff, moduleTitle=Clin Cancer Res：利妥昔單抗+來那度胺→來那度胺治療惰性非霍奇金淋巴瘤的長期預后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=aac0216893ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
